Date published: 2025-9-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-defensin 9 Inhibitors

β-defensin 9 inhibitors are a class of chemical compounds that specifically interact with and inhibit the function of β-defensin 9, a small cationic peptide belonging to the defensin family. Defensins are a group of host defense peptides that play a crucial role in the innate immune system of many organisms, including humans. β-defensin 9, in particular, is characterized by its broad-spectrum antimicrobial activity and its role in modulating immune responses. The inhibition of β-defensin 9 typically involves binding to the peptide or interacting with its active sites to prevent it from exerting its biological functions. This inhibition can affect processes like cell signaling, membrane interaction, or peptide binding, depending on the specific mode of action of the inhibitor. Chemical entities identified as β-defensin 9 inhibitors often possess unique structural features that allow for a high degree of specificity and binding affinity, which are critical for effectively modulating the biological pathways in which β-defensin 9 is involved.

Research into β-defensin 9 inhibitors often focuses on understanding the structural and biochemical characteristics that govern their interaction with β-defensin 9. This includes studies on the molecular dynamics of the inhibitor-peptide complex, the thermodynamics of binding, and the conformational changes induced upon inhibitor binding. Such inhibitors are valuable tools in the study of β-defensin 9's function in cellular processes and its interactions with microbial membranes or immune cells. Additionally, these inhibitors can be useful in exploring the broader role of defensins in immunity and inflammation. Structural studies often employ techniques such as X-ray crystallography, NMR spectroscopy, and computational modeling to elucidate the precise nature of the binding interaction between the inhibitors and β-defensin 9. The development and characterization of β-defensin 9 inhibitors provide insight into the fundamental aspects of peptide function and regulation, contributing to a deeper understanding of immune system modulation at the molecular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002, inhibiting the PI3K/AKT pathway, influences β-defensin 9 by disrupting the downstream signaling, altering its expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin, inhibiting mTOR, indirectly influences β-defensin 9 by modulating mTOR-related pathways, leading to alterations in peptide expression.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

Bay 11-7082 modulates NF-κB, impacting β-defensin 9 regulation by influencing NF-κB-mediated transcriptional control of the gene.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059, a MAPK pathway inhibitor, indirectly affects β-defensin 9 by modulating the MAPK signaling cascade, leading to altered gene expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin, inhibiting the PI3K/AKT pathway, indirectly influences β-defensin 9 expression by disrupting the downstream signaling cascade.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580, a p38 MAPK inhibitor, indirectly influences β-defensin 9 by altering the cellular environment through p38 MAPK pathway inhibition.

NFκB Activation Inhibitor II, JSH-23

749886-87-1sc-222061
sc-222061C
sc-222061A
sc-222061B
5 mg
10 mg
50 mg
100 mg
$210.00
$252.00
$1740.00
$1964.00
34
(1)

A selective NF-κB inhibitor, indirectly modulates β-defensin 9 by impacting NF-κB-mediated transcriptional control of the gene.

MK-2206 dihydrochloride

1032350-13-2sc-364537
sc-364537A
5 mg
10 mg
$178.00
$325.00
67
(1)

MK-2206, inhibiting the PI3K/AKT pathway, indirectly influences β-defensin 9 by disrupting the downstream signaling cascade, altering its expression.

LY 303511

154447-38-8sc-202215
sc-202215A
1 mg
5 mg
$66.00
$273.00
3
(1)

LY303511, a PI3K/AKT pathway inhibitor, indirectly influences β-defensin 9 by disrupting the downstream signaling cascade, leading to altered gene expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

SP600125, a JNK inhibitor, indirectly influences β-defensin 9 by modulating the JNK signaling cascade, altering the cellular environment and gene expression.